期刊文献+

头颈部骨外尤文氏肉瘤4例并文献复习 被引量:10

Four cases of extraskeletal Ewing′s sarcoma in the head and neck and literature review
原文传递
导出
摘要 目的:探讨头颈部骨外尤文肉瘤的临床特征、诊疗方法及预后。方法:分析4例头颈部骨外尤文肉瘤的临床资料,并结合相关文献讨论。结果:4例患者中,发生于鼻腔、鼻窦2例,口咽部1例,皮肤软组织1例,所有患者均通过组织病理及免疫组织化学确诊。2例患者接受以手术为主的综合治疗,分别随访7年及7个月无复发和转移;1例单纯手术者随访至6个月时因肺转移死亡;余1例单纯化疗者在治疗过程中因远处转移死亡。结论:头颈部骨外尤文肉瘤极少见,临床表现无特异性,早期诊断困难,多采用综合治疗方案。本病易复发,转移率高,预后不佳。 Objective:To evaluate the clinical features,diagnosis,treatment and prognosis of the extraskeletal Ewing's sarcoma in the head and neck. Method:The clinical data of four cases of extraskeletal Ewing's sarcoma was analysed and relevant literatures were reviewed. Result: Two cases originated from the nasal cavity and paranasal si nuses, the other two cases originated from the oral pharynx and skin respectively. The tumors were all diagnosed via histopathology and immunohistochemistry. Two cases were treated by combined modality therapy and did not recur or metastasize after follow-up for 7 months and 7 years respectively. Another one was treated by surgery and died after 6 months of follow-up. The remaining one was treated by chemotherapy and died with metastasis during the period of therapy. Conclusion: The extraskeletal Ewing's sarcoma, which is rare arising from the head and neck, has non-specific clinical manifestation and difficulty in early diagnosis. The disease can be effectively treated by combined therapy, but the high recurrent and metastatic rates usually result in poor prognosis.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2013年第18期1000-1002,1005,共4页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 国家自然科学基金(No:81170898)
关键词 头颈部肿瘤 骨外尤文氏肉瘤 诊断 治疗 head and neck neoplasm extraskeletal Ewing's sarcoma diagnosis therapy
  • 相关文献

参考文献17

  • 1TEFFT M, VAWTER (; F, MITUS A. Paraverte bral: "Round cell" tumors in children[J]. Radiology, 1969,92:1501-1509.
  • 2TURAL D, MOI.INAS MANDEL N, DERVISO GI.U S, et al. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome[J]. JpnJ ClinOncol, 2012,42:420 426.
  • 3YESHVANTH S K, NINAN K, BHANDARY S K, et al. Rare case of extreskeletal Ewings sarcoma of the sinonasal tract[J]. J Cancer Res Ther, 2012,8: 142-144.
  • 4APPLEBAUM M A, GOLDSBY R, NEUHAUSJ, et al. Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement [J ]. Pediatr Blood Cancer, 2012,59 : 617 - 620.
  • 5JAVERY O, KRAJEWSKI K, O'REGAN K, et al. A to Z of Extraskeletal Ewing sarcoma family of tumors in adults: imaging features of primary dis ease, metastatic patterns, and treatment responses [J]. Am J Roentgenol,2011,197:1015-1022.
  • 6KANG M S, YOON H K, CHOI J B, et al. Ex- traskeletal Ewing's sarcoma of the hard palate[J]. J Korean Med Sci, 2005,20 : 687- 690.
  • 7LLOMBART-BOSCH A, MACHADO I, NAVAR- RO S, et al. Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support [J]. Virchows Arch,2009,455: 397-411.
  • 8CETINER H, KIR G, GELMANN E P, et al. Pri- mary vulvar ewing sarcoma/primitive neuroeetodermal tumor-a report of 2 cases and review of the literature [J]. Int J Gynecol Cancer, 2009, 19:1131-1136.
  • 9LUDWIG J A. Ewing sarcoma., historical perspec- tives, current state-of-the-art, and opportunities for targeted therapy in the future[J]. Curr Opin Onco[, 2008,20:412-418.
  • 10DONALDSON S S. Ewing sarcoma., radiation dose and target volume [J]. Pediatr Blood Cancer, 2004, 42: 471-476.

二级参考文献42

  • 1Iwamoto Y. Diagnosis and treatment of Ewing's sarcoma. Jpn J Clin Oncol, 2007; 37(2):79-89
  • 2Maksimenko A, Malvy C Oncogene-targeted antisense oligonucleotides for the treatment of Ewing's sarcoma. Expert Opin Ther Targets, 2005; 9(4):825-830
  • 3Chansky HA, Barahmand-Pour F, Mei Q, et al. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing' s sarcoma cells in vitro. J Orthop Res, 2004; 22(4):910-917
  • 4Dohjima T, Lee NS, Li H, et al. Small interfering RNAs expressed from a Pol Ⅲ promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line. Mol Ther, 2003; 7(6):811-816
  • 5Hu-Lieskovan S, Heidel JD, Bartlett DW, et al. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of rnetastalic Ewing' s sarcoma. Cancer Res, 2005, 65(19):8984-8992
  • 6Maksimenko A, Malvy C, Lambert G, et al. Oligonudeotides targeted against a junction oncogene are made efficient by nanotechnologies. Pharm Res, 2003; 20 (10): 1565-1567
  • 7Mateo-Lozano S, Gokhale PC, Soldatenkov VA, et al. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma. Clin Cancer Res, 2006, 12(22):6781-6790
  • 8Tirado OM, Mateo-Lozano S, Villar J, et al. Caveolin-1 (CAV1) is a target of EWS/FLI- 1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells. Cancer Res, 2006, 66(20) :9937-9947
  • 9Chan D, Wilson TJ, Xu D, et al. Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1. Br J Cancer, 2003; 88 (1):137-145
  • 10Manara MC, Perdichizzi S, Serra M, et al. The molecular mechanisms responsible for resistance to ET-743 (Trabectidin ; Yondelis) in the Ewing's sarcoma cell line, TC-71. Int J Oncol, 2005, 27(6):1605-1616

共引文献1

  • 1蔡博宇,林柏键,查旭东,朱雅静,王天宇,梁才全,彭浒,曹皓天,祝峙,刘环海,廖建春.原发性会厌尤文肉瘤1例[J].中国耳鼻咽喉颅底外科杂志,2023,29(4):94-95.

同被引文献40

引证文献10

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部